[Delayed]Takara Bio Announces Transfer of SAKIGAKE and Orphan Designations for NY-ESO-1/siTCR Gene Therapy Product | IR News | News Release ＆ IR News | Investor Relations Read more
Spin-off of GE HealthCare creates global leader in Precision Care GE HealthCare to begin trading on The Nasdaq Stock Market LLC (“Nasdaq”) on January 4, 2023, under ticker “GEHC”; GE will continue to trade on New York Stock Exchange (“NYSE”) under ticker “GE” GE remains on track to launch GE Aerospace and GE Vernova[1] as... Read more
Greater Scale, Broader Capabilities to Deliver Foundational Solutions for a Connected World ANDOVER, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, announced that it will share its long-term Read more
Board sets GE HealthCare distribution date of January 3, 2023, after market close GE shareholders will receive one share of GE HealthCare for every three shares owned GE HealthCare to begin trading on The Nasdaq Market LLC (“Nasdaq”) on January 4, 2023 under ticker “GEHC”, and GE will continue to trade on NYSE BOSTON –... Read more
BOSTON – November 22, 2022 – General Electric Company (“GE”) (NYSE: GE) announced today that GE Healthcare Holding LLC (“GE HealthCare”), a direct, wholly-owned subsidiary of GE, has closed its previously announced offering of $1,000,000,000 aggregate principal amount of 5.550% senior notes due 2024 (the “2024 notes”), $1,500,000,000 aggregate principal amount of 5.600% senior notes... Read more
ANDOVER, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, announced today that it will host an Analyst Day in Boston on Wednesday, December 14, 2022 at 9:00 a.m. Read more